Alcon announces u.s. launch of voyager dslt, first-of-its-kind treatment for glaucoma and ocular hypertension

Geneva--(business wire)--alcon announces u.s. launch of voyager dslt, first-of-its-kind treatment for glaucoma and ocular hypertension.

ALC Ratings Summary

ALC Quant Ranking